|Alma mater||Yale College, Harvard Medical School|
|Known for||pioneering Zebrafish research in cardiology|
|Awards||Institute of Medicine member, Fellow of the American Academy of Arts and Sciences|
|Institutions||Novartis Institutes of BioMedical Research, Massachusetts General Hospital, Harvard Medical School|
Mark Fishman is an American cardiologist. A researcher and clinician in cardiology, he is the previous President of the Novartis Institutes for BioMedical Research (NIBR), the main research arm of Novartis Pharmaceuticals.
Fishman was appointed President of the newly founded Novartis Institutes for BioMedical Research in 2002 to implement a new strategy in Novartis' global drug discovery effort. He is the author of over 100 publications and known for pioneering research using the zebrafish as a means of visualizing the development of the circulatory system and as a model for human disease.
He was previously a Professor of Medicine at Harvard Medical School, Chief of Cardiology at Massachusetts General Hospital, and director of the Cardiovascular Research Center at Massachusetts General Hospital. He is a fellow of the National Academy of Arts and Sciences and a member of the National Academy of Sciences, Institute of Medicine.
After being the head of Novartis for 13 years, he has decided to retire in 2016.
- "Archived copy". Archived from the original on 2011-06-16. Retrieved 2009-10-20.
- http://www.pubmed.gov 183 results as of 20 Oct 2009
- "Fierce Biotech". Retrieved 13 December 2016.